Baosheng Science and Technology Innovation Co.,Ltd.

SSE:600973.SS

4.4 (CNY) • At close April 22, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001
Revenue 46,360.04643,798.33741,481.57442,878.35834,138.49533,282.92232,184.40420,691.16415,126.69912,988.4312,162.3769,807.8638,569.4756,935.1215,765.8733,878.9834,525.5683,925.3012,543.7491,296.5341,034.788711.092490.348407.453
Cost of Revenue 44,301.94541,483.1139,357.94140,140.05731,796.32831,113.73430,183.16319,473.85413,866.03711,900.99711,283.1099,010.1997,840.3336,468.7725,261.163,418.7154,110.8343,369.0522,117.681,056.141826.064574.067369.678296.053
Gross Profit 2,058.1012,315.2282,123.6332,738.3012,342.1672,169.1882,001.2411,217.311,260.6611,087.433879.267797.664729.141466.349504.713460.268414.734556.249426.069240.393208.724137.025120.67111.4
Gross Profit Ratio 0.0440.0530.0510.0640.0690.0650.0620.0590.0830.0840.0720.0810.0850.0670.0880.1190.0920.1420.1670.1850.2020.1930.2460.273
Reseach & Development Expenses 700.226748.071705.213718.513494.081424.267452.444347.652258.21732.05256.0180000000000000
General & Administrative Expenses 146.754152.329154.075147.32170.163145.09980.642108.88348.77531.76952.74654.68144.86232.59530.24979.41777.22391.061105.2969.63448.06421.26320.25119.369
Selling & Marketing Expenses 190.082342.133335.507427.048675.808577.301466.906387.8419.642354.665265.854283.377289.476221.112211.954227.89198.303201.64160.71194.1886.80363.37447.34943.142
SG&A 336.836486.053489.581574.368845.971722.401547.548496.683468.417386.434318.6338.059334.338253.707242.202307.308275.527292.701266.001163.814134.86784.63767.662.511
Other Expenses 1,379.5441,047.016383.324355.436251.181301.451-1.97110.20846.9396.526.1899.52522.23515.79411.71710.693-6.3843.41617.86113.1410.95621.68318.17318.355
Operating Expenses 2,416.6072,281.141,578.1191,648.3171,591.2331,448.1191,267.741716.361711.189586.771461.018456.128426.187324.948304.549311.752284.136302.229271.992168.423139.09986.60969.5464.483
Operating Income -358.506534.624663.3711,135.44768.297741.527185.099113.11285.338194.272156.34113.595105.3737.3102.992114.4520.809189.553152.00475.21365.20550.77944.34342.402
Operating Income Ratio -0.0080.0120.0160.0260.0230.0220.0060.0050.0190.0150.0130.0120.0120.0010.0180.030.0050.0480.060.0580.0630.0710.090.104
Total Other Income Expenses Net -0.726-479.555-569.524-1,839.869-454.017-492.098-481.678-315.189-173.924-253.615-219.309-174.938-141.032-83.64-52.25210.693-116.174-61.0520.019-1.354-16.087-1.796-0.008-1.015
Income Before Tax -359.23255.06993.847-705.444329.481249.429185.753120.694331.295199.512159.644123.031123.44923.094114.709125.14314.425192.968152.02373.85964.8548.98244.33541.387
Income Before Tax Ratio -0.0080.0010.002-0.0160.010.0070.0060.0060.0220.0150.0130.0130.0140.0030.020.0320.0030.0490.060.0570.0630.0690.090.102
Income Tax Expense -36.8579.4929.466-59.53774.05459.35739.06534.7260.66132.92930.27322.75727.5145.10820.58319.9959.31157.02647.62225.32725.32717.44915.228.738
Net Income -299.86231.02465.339-645.906227.142154.026117.69486.237265.669160.501128.67499.357100.59417.98694.126105.1485.114135.693104.29748.53239.52331.53329.11532.649
Net Income Ratio -0.0060.0010.002-0.0150.0070.0050.0040.0040.0180.0120.0110.010.0120.0030.0160.0270.0010.0350.0410.0370.0380.0440.0590.08
EPS -0.220.020.048-0.470.170.130.0960.0710.30.160.140.110.110.0320.140.150.0070.20.160.0710.0580.0740.0430.048
EPS Diluted -0.220.020.048-0.470.170.130.0960.0710.30.160.140.110.110.0320.140.150.0070.20.160.0710.0580.0740.0430.048
EBITDA 707.2651,080.5041,170.434349.0851,203.5951,082.834963.714731.81772.949637.002494.334399.379373.839186.424236.54218.794176.699295.534202.924105.32894.35173.40356.82653.427
EBITDA Ratio 0.0150.0250.0280.0080.0350.0330.030.0350.0510.0490.0410.0410.0440.0270.0410.0560.0390.0750.080.0810.0910.1030.1160.131